Expanding HTA - Correcting a Misattribution, Clarifying the Scope of HTA and CEA; Comment on "Ethics in HTA: Examining the 'Need for Expansion'"
<span class="fontstyle0">Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) a...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Kerman University of Medical Sciences,
2019-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <span class="fontstyle0">Abrishami, Oortwijn, and Hofman (AOH) attribute to me a position I do not hold and an argument I did not make. The purpose of this note is make clear what my position actually is and to clarify the main differences between health technology assessment (HTA) and cost-effectiveness analysis (CEA).</span> |
|---|---|
| Item Description: | 2322-5939 2322-5939 10.15171/ijhpm.2019.73 |